PART I . Overview Our Business We are a cell therapy company focused on immunotherapy. Since our inception, we have been involved with the development of proprietary immune system management technology (Cell Source technology) licensed from Yeda Research & Development Company Limited (Yeda), the commercial arm of the Weizmann Institute of Science (Weizmann Institute) in Israel. The current focus of our Research and Development efforts is at the University of Texas MD Anderson Cancer Center (MD A...
Q2 FY2026 — expected 2026-07-22
| Type | Subject | Detail | Quarter |
|---|---|---|---|
| topic_mention | CLCS | discussed_in_filing Cybersecurity | |
| topic_mention | CLCS | discussed_in_filing Trusted Computing | |
| topic_mention | CLCS | discussed_in_filing Blockchain & Crypto | |
| topic_mention | CLCS | discussed_in_filing Regulation | |
| topic_mention | CLCS | discussed_in_filing Healthcare & Bio | |
| topic_mention | CLCS | discussed_in_filing Sovereign & Government | |
| topic_mention | CLCS | discussed_in_filing Cybersecurity | |
| topic_mention | CLCS | discussed_in_filing Trusted Computing | |
| topic_mention | CLCS | discussed_in_filing Blockchain & Crypto | |
| topic_mention | CLCS | discussed_in_filing Regulation | |
| topic_mention | CLCS | discussed_in_filing Healthcare & Bio | |
| topic_mention | CLCS | discussed_in_filing Sovereign & Government | |
| topic_mention | CLCS | discussed_in_filing Cybersecurity | |
| topic_mention | CLCS | discussed_in_filing Trusted Computing | |
| topic_mention | CLCS | discussed_in_filing Blockchain & Crypto | |
| topic_mention | CLCS | discussed_in_filing Regulation | |
| topic_mention | CLCS | discussed_in_filing Healthcare & Bio | |
| topic_mention | CLCS | discussed_in_filing Sovereign & Government | |
| topic_mention | CLCS | discussed_in_filing Cybersecurity | |
| topic_mention | CLCS | discussed_in_filing Trusted Computing |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2024-06-24 | 2023-12-31 | 0001493152-24-024903 | EDGAR | 78K words |
| 2023-08-08 | 2022-12-31 | 0001493152-23-027069 | EDGAR | — |
| 2022-04-15 | 2021-12-31 | 0001493152-22-010133 | EDGAR | — |
| 2021-04-15 | 2020-12-31 | 0001640334-21-000923 | EDGAR | — |
| 2020-03-30 | 2019-12-31 | 0001640334-20-000672 | EDGAR | — |
| 2019-04-01 | 2018-12-31 | 0001165527-19-000034 | EDGAR | — |
| 2018-07-25 | 2017-12-31 | 0001165527-18-000154 | EDGAR | — |
| 2016-04-14 | 2015-12-31 | 0001165527-16-000733 | EDGAR | — |
| 2015-03-13 | 2014-12-31 | 0001144204-15-015954 | EDGAR | — |
| 2014-03-25 | 2013-12-31 | 0001165527-14-000161 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2024-11-14 | 2024-09-30 | 0001493152-24-045964 | EDGAR | 23K words |
| 2024-08-19 | 2024-06-30 | 0001493152-24-033055 | EDGAR | — |
| 2024-07-29 | 2024-03-31 | 0001493152-24-029448 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001493152-23-040079 | EDGAR | — |
| 2023-09-19 | 2023-06-30 | 0001493152-23-033011 | EDGAR | — |
| 2023-08-23 | 2023-03-31 | 0001493152-23-029915 | EDGAR | — |
| 2022-12-08 | 2022-09-30 | 0001493152-22-034876 | EDGAR | — |
| 2022-12-02 | 2022-06-30 | 0001493152-22-034255 | EDGAR | — |
| 2022-11-02 | 2022-03-31 | 0001493152-22-030233 | EDGAR | — |
| 2021-11-15 | 2021-09-30 | 0001493152-21-028675 | EDGAR | — |
| 2021-08-12 | 2021-06-30 | 0001493152-21-019491 | EDGAR | — |
| 2021-05-17 | 2021-03-31 | 0001493152-21-011971 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2025-06-27 | 0001641172-25-016833 | EDGAR | 1K words |
| 2024-04-09 | 0001493152-24-014035 | EDGAR | — |
| 2022-07-21 | 0001493152-22-019997 | EDGAR | — |
| 2022-05-06 | 0001493152-22-012387 | EDGAR | — |
| 2022-03-11 | 0001493152-22-006672 | EDGAR | — |
| 2021-04-02 | 0001640334-21-000755 | EDGAR | — |
| 2019-04-19 | 0001165527-19-000053 | EDGAR | — |
| 2015-11-16 | 0001165527-15-000545 | EDGAR | — |
| 2015-11-05 | 0001165527-15-000524 | EDGAR | — |
| 2015-08-19 | 0001165527-15-000418 | EDGAR | — |
75 total filings indexed. 43 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001569340 |
| Ticker | CLCS |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | NV |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report